Ensysce Biosciences Inc.

NASDAQ: ENSC · Real-Time Price · USD
2.10
0.04 (1.94%)
At close: Aug 15, 2025, 3:06 PM

Ensysce Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-7.99M -10.63M -24.21M -29.15M
Depreciation & Amortization
n/a n/a n/a 151.00
Stock-Based Compensation
110.72B 879.16K 1.07M 121.76K
Other Working Capital
-245.77K 107.95K 2.67M 561.72K
Other Non-Cash Items
-7,613.4B -85.79K -233.42K 7.49M
Deferred Income Tax
n/a n/a n/a 14.6M
Change in Working Capital
-851.25K -947.08K 5.48M -1.3M
Operating Cash Flow
-7,502.7B -10.78M -17.89M -8.24M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a 4.5K n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a 4.5K n/a
Debt Repayment
-485.19K 605.43K 6.13M 13.91M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-290M n/a -913.2K -803.14B
Other Financial Acitivies
9,881.5B -899.55K 317.69K 803.14B
Financial Cash Flow
9,881.2B 8.76M 8.77M 20.31M
Net Cash Flow
2,378.5B -2.02M -9.12M 12.07M
Free Cash Flow
-7,502.7B -10.78M -17.89M -8.24M